Evidence map›Paper›PMID 40314237›Full record

ArticleActa crystallographica. Section F, Structural biology communications2025

Structure of an Fe

Tingfei Chen, Christoph Buhlheller, Houfu Guo

Abstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tingfei ChenDepartment of Molecular and Cellular Biochemistry, Markey Cancer Center, University of Kentucky, 741 South Limestone Avenue, Lexington, KY 40536-0509, USA.
Christoph BuhlhellerMedical University of Graz, Graz, Austria.ORCID 0000-0001-9358-5316
Houfu GuoDepartment of Molecular and Cellular Biochemistry, Markey Cancer Center, University of Kentucky, 741 South Limestone Avenue, Lexington, KY 40536-0509, USA.ORCID 0000-0002-3659-9399

Funding

Mechanistic and structural insights into a new pro-metastatic collagen glucosyltransferaseR37CA278989 · NCI · UNIVERSITY OF KENTUCKY · PI Houfu Guo · 2024 to 2026
$1.6M
Determining structural features of a collagen lysyl hydroxylase that promotes lung cancer metastasisR00CA225633 · NCI · UNIVERSITY OF KENTUCKY · PI GUO, HOUFU · 2020 to 2022
$730k
American Cancer Society Research Scholar Grant RSG-24-1156098-01-MMNational Institutes of Health, National Cancer Institute R00CA225633National Institutes of Health, National Cancer Institute R37CA278989NCI NIH HHS R00 CA225633NCI NIH HHS R37 CA278989
6 · The paper itself

Abstract

Collagen lysyl hydroxylases catalyze the hydroxylation of collagen lysine residues during collagen synthesis in animals and mimiviruses. Lysyl hydroxylation is crucial for collagen fibrogenesis and function. We previously demonstrated that recombinant mimiviral and human collagen lysyl hydroxylases, isolated from bacterial and mammalian cells, have Fe

Indexed as

CollagenIronProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenaseAmino Acid SequenceBinding SitesCatalytic DomainCrystallography, X-RayEscherichia coliHumansModels, MolecularProtein BindingProtein MultimerizationRecombinant ProteinsCollagenIronProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenaseRecombinant ProteinsdioxygenasesDNA virusespost-translational modifications

Identifiers

PMID40314237
PMCPMC12121394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.